You are here

Coronary Intervention & Surgery


After one year, patients with long coronary lesions who were implanted with an intravascular ultrasound-guided everolimus-eluting stent had a significantly lower rate of major adverse cardiac events compared with those implanted with an angiography-guided stent.


Recent Headlines

Medtronic acquires Aircraft Medical for $110 million in cash

Medtronic announced on Nov. 18 it had acquired Aircraft Medical, a company that develops video laryngoscopes that anesthesiologists and critical care professionals use to intubate patients.

AHA.15: Patients with diabetes have increased long-term risk of stroke following CABG

The long-term risk of stroke after patients underwent CABG was significantly higher in patients with type 1 or type 2 diabetes compared with those who did not have diabetes, according to an analysis from Swedish researchers.

AHA.15: Dual antiplatelet therapy following transcatheter ASD closure reduces number and severity of migraine headaches

For patients undergoing transcatheter atrial septal defect (ASD) closure, the use of dual antiplatelet therapy consisting of clopidogrel and aspirin led to fewer migraine headaches and less severe migraine episodes compared with taking aspirin alone, according to a randomized, double-blind trial.

AHA.15: Two-year survival similar among surgical options for severe ischemic mitral regurgitation

After two years, patients who underwent mitral valve repair or replacement for severe ischemic mitral regurgitation had no statistically significant difference in mortality, overall readmissions or serious adverse events, according to a randomized trial. However, patients in the repair group had a higher rate of recurrent mitral regurgitation and were more likely to have a heart failure adverse event, cardiovascular readmission and quality of life score.

AHA.15: Appropriate use criteria significantly changes patient selection for PCI

Since the American College of Cardiology, American Heart Association (AHA) and other medical societies released appropriate use criteria for coronary revascularization in 2009, the number of nonacute PCIs has significantly decreased, according to a multicenter, longitudinal, cross-sectional analysis. 

Researchers attempt to allay TAVR concerns

Soon after a study appeared in The New England Journal of Medicine on Oct. 5 finding potential issues with bioprosthetic aortic valves, the results generated national attention, causing some to question the use of transcatheter aortic valve replacement (TAVR) treatment.

Early invasive treatment strategy after acute coronary syndrome appears to be effective

Patients with acute coronary syndromes who underwent an early invasive strategy had a lower risk of cardiac death and hospitalization for MI compared with those who received a conservative approach, according to a retrospective cohort study.

IABP therapy is associated with higher mortality in patients undergoing PCI

An observational study involving Japanese patients undergoing PCI found the use of intra-aortic balloon pump (IABP) therapy was associated with a significantly higher risk of in-hospital mortality.

Quest voluntarily recalls some of its MPS delivery sets for use during open heart surgery

Quest Medical voluntarily recalled certain lots of its Myocardial Protection System (MPS) delivery sets on Oct. 28 after finding the products had a possible seal failure that could lead to blood loss in patients.

ACC, AHA, SCAI release updated guidelines on multivessel PCI and thrombus aspiration

Major medical societies released updated guidelines on Oct. 21 regarding multivessel PCI and thrombus aspiration in patients with STEMI undergoing primary PCI.